1. Home
  2. ASH vs ELVN Comparison

ASH vs ELVN Comparison

Compare ASH & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ashland Inc.

ASH

Ashland Inc.

HOLD

Current Price

$57.96

Market Cap

2.4B

ML Signal

HOLD

Logo Enliven Therapeutics Inc.

ELVN

Enliven Therapeutics Inc.

HOLD

Current Price

$39.55

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASH
ELVN
Founded
1924
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.6B
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
ASH
ELVN
Price
$57.96
$39.55
Analyst Decision
Buy
Strong Buy
Analyst Count
7
5
Target Price
$65.57
$43.40
AVG Volume (30 Days)
1.0M
563.9K
Earning Date
04-28-2026
05-11-2026
Dividend Yield
3.38%
N/A
EPS Growth
N/A
3.17
EPS
0.08
N/A
Revenue
$1,824,000,000.00
N/A
Revenue This Year
$2.58
N/A
Revenue Next Year
$4.28
N/A
P/E Ratio
$716.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$46.30
$14.79
52 Week High
$65.65
$48.53

Technical Indicators

Market Signals
Indicator
ASH
ELVN
Relative Strength Index (RSI) 58.14 43.32
Support Level $47.57 $38.58
Resistance Level $60.79 $40.62
Average True Range (ATR) 2.00 2.24
MACD 0.31 -0.29
Stochastic Oscillator 86.40 12.81

Price Performance

Historical Comparison
ASH
ELVN

About ASH Ashland Inc.

Ashland Inc. is a specialty materials company serving markets including pharmaceuticals, personal care, food and beverages, coatings, construction, energy, and electronics. It operates through four segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Life Sciences contributes the highest revenue, offering functional additives for pharmaceutical and nutrition applications. Personal Care provides ingredients for skin, hair, oral care, and household products, while Specialty Additives supplies performance-enhancing additives for coatings and. Intermediates produce BDO and related derivatives used in polymers, electronics, agriculture, and pharmaceutical applications. The company generates sales across North America, Europe, Asia Pacific, Latin America, and regions.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Share on Social Networks: